Full Name | Amy Durkin |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 25 Court St, Cromwell, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275050791 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amy Durkin, 25 Court St, Cromwell, CT 06416-1672 Ph: () - | Amy Durkin, 25 Court St, Cromwell, CT 06416-1672 Ph: (860) 688-6443 |
News Archive
The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.
Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report released today by the American Society of Clinical Oncology. The report stresses, however, that recent budget cuts and years-long flat funding can only delay efforts to translate research into effective treatments for millions of individuals with cancer.
SRI International Dedicates New Tampa Bay Research Facility
It has come to health officials' attention nationwide that there is a serious rise of abuse of painkillers, especially opioids. Federal officials recently stepped up plans to monitor frequent prescribers and users.
Two well-known superbugs are the gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). A new drug Teixobactin has shown promise against these microbes. The study titled, "The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study," was published in the latest issue of the journal Therapeutics and Prevention.
› Verified 9 days ago
Lourdes M Tuquinahui, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 West St Ste F, Cromwell, CT 06416 Phone: 860-613-9930 | |
Brandy Vanwinkle, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 52 Missionary Rd, Cromwell, CT 06416 Phone: 860-398-6049 | |
Kristin Nierman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 West St Ste F, Cromwell, CT 06416 Phone: 860-613-9930 Fax: 860-613-9952 | |
Emily Petrone, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 West St Bldg 2, Cromwell, CT 06416 Phone: 860-613-9930 | |
Sarah Schortman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 52 Missionary Rd, Cromwell, CT 06416 Phone: 860-754-3048 | |
Miss Jacqueline P Donahue, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 West St Ste F, Cromwell, CT 06416 Phone: 860-613-9930 Fax: 860-613-9952 | |
Sarah Jane Kickham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 162 West St Ste F, Cromwell, CT 06416 Phone: 860-613-9930 |